feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts",https://benzinga.com/general/biotech/21/11/24038588/the-daily-biotech-pulse-eisai-gilead-tout-positive-phase-2-data-for-new-alzheimers-treatment-comp,https://j.mp/3wD9Mgp
